Vahit Özmen1, Nergiz Dağoğlu2, İsmet Dede3, Adem Akçakaya4, Mustafa Kerem5, Fatih Göksel6, Enver Özgür7, Emel Başkan8, Mustafa Yaylacı9, Adil Ceydeli10, Meltem Baykara11, Huriye Şenay Kızıltan12, Şeref Kömürcü13, Mahmut Gümüş14, H Mehmet Türk14, Recep Demirhan15, Ali Akgün16, Naim Kadoglou17, Emre Yatman8, Cem Cüneyt Elbi18, Seza Güleç19, Atilla Soran20, Ahmet Özet21, Fahrettin Keleştimur22. 1. Department of General Surgery, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey. 2. Department of Radiation Oncology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey. 3. Cancer Surgeon General Office, İstanbul, Turkey. 4. Department of General Surgery, Bezmialem University Faculty of Medicine, İstanbul, Turkey. 5. Department of General Surgery, Gazi University Faculty of Medicine, İstanbul, Turkey. 6. Clinic of General Surgery, Ankara Oncology Training and Research Hospital, Ankara, Turkey. 7. Department of Urology, Köln University Faculty of Medicine, Köln, Germany. 8. Turkey Public Hospitals Institution, Ankara, Turkey. 9. Clinic of Medical Oncology, İstanbul Bayındır Hospital, İstanbul, Turkey. 10. Florida Plastic Surgery Institute, Florida, USA. 11. Clinic of Medical Oncology, Sakarya Training and Research Hospital, Sakarya, Turkey. 12. Department of Radiation Oncology, Bezmialem University Faculty of Medicine, İstanbul, Turkey. 13. Clinic of Medical Oncology, Memorial Hospital, İstanbul, Turkey. 14. Department of Medical Oncology, Bezmialem University Faculty of Medicine, İstanbul, Turkey. 15. Clinic of Thoracic Surgery, Kartal Dr. Lütfü Kırdar Training and Research Hospital, İstanbul, Turkey. 16. Specialty Scanners Ltd, UK. 17. Department of General Surgery, National Health System-Konsultan, Pittsburgh, USA. 18. Bayer Healthcare, USA. 19. Department of General Surgery, Florida International University, Florida, USA. 20. Department of General Surgery, Pittsburgh University Faculty of Medicine, Pittsburgh, USA. 21. National Cancer Institute President. 22. Turkey Health Institute President.
Abstract
OBJECTIVE: There is an increase in the incidence of cancer, and consequently in mortality rates, both in the world and in Turkey. The increase in the incidence and mortality rate of cancer are more prominent in our country as well as in other developing countries. The aim of this workshop was to determine the current status on prevention, screening, early diagnosis and treatment of cancer in our country, to identify related shortcomings, specify solutions and to share these with health system operators, and to aid in implementation of these systems. Developments on palliative care were also evaluated. MATERIALS AND METHODS: The current situation in the practice of clinical oncology, related drawbacks, problems encountered during multidisciplinary approach and their solutions were discussed under several sub-headings during a 3-day meeting organized by the Turkish Ministry of Health (Türkiye Cumhuriyeti Sağlık Bakanlığı-TCSB) with participation of 16 scientists from Turkey and 6 from abroad, and the conclusions were reported. RESULTS: It is expected that the newly established Turkish Health Institutes Association (Türkiye Sağlık Enstitüleri Başkanlığı-TÜSEB) and the National Cancer Institute (Ulusal Kanser Enstitüsü) will provide a new framework in the field of oncology. The current positive findings include the increase in the number of scientists who carry out successful trials in oncology both in Turkey and abroad, the implementation of the national cancer registry program by the Cancer Control Department and the breast cancer registry program by the Turkish Federation of Breast Diseases Societies (Türkiye Meme Hastalıkları Dernekleri Federasyonu-TMHDF), and introduction of Cancer Early Diagnosis, Screening, and Training Centers (Kanser Erken Tanı, Tarama ve Eğitim Merkezi-KETEM) for the application of community-based cancer screening programs. In addition to these, obvious shortcomings related to education, implementation, management and research issues were also determined, and policy and project proposals to address these issues were presented. Collaboration with relevant organizations in the implementation of these studies was supported. CONCLUSION: Both the incidence and mortality rates of cancer are increasing in Turkey. The widespread deficiencies in population-based screening and in effective treatment lead to an increase in delay in diagnosis and mortality. Despite improvements in data recording, screening and treatment over the last 10 years, extensive, organized, population-based screening programs and fully equipped early diagnosis and treatment centers are required. Enhancement of basic cancer epidemiologic, translational, genetic and molecular research studies is essential in our country. Improvements on pain treatment and palliative care of patients with chronic and terminal cancer are also required.
OBJECTIVE: There is an increase in the incidence of cancer, and consequently in mortality rates, both in the world and in Turkey. The increase in the incidence and mortality rate of cancer are more prominent in our country as well as in other developing countries. The aim of this workshop was to determine the current status on prevention, screening, early diagnosis and treatment of cancer in our country, to identify related shortcomings, specify solutions and to share these with health system operators, and to aid in implementation of these systems. Developments on palliative care were also evaluated. MATERIALS AND METHODS: The current situation in the practice of clinical oncology, related drawbacks, problems encountered during multidisciplinary approach and their solutions were discussed under several sub-headings during a 3-day meeting organized by the Turkish Ministry of Health (Türkiye Cumhuriyeti Sağlık Bakanlığı-TCSB) with participation of 16 scientists from Turkey and 6 from abroad, and the conclusions were reported. RESULTS: It is expected that the newly established Turkish Health Institutes Association (Türkiye Sağlık Enstitüleri Başkanlığı-TÜSEB) and the National Cancer Institute (Ulusal Kanser Enstitüsü) will provide a new framework in the field of oncology. The current positive findings include the increase in the number of scientists who carry out successful trials in oncology both in Turkey and abroad, the implementation of the national cancer registry program by the Cancer Control Department and the breast cancer registry program by the Turkish Federation of Breast Diseases Societies (Türkiye Meme Hastalıkları Dernekleri Federasyonu-TMHDF), and introduction of Cancer Early Diagnosis, Screening, and Training Centers (Kanser Erken Tanı, Tarama ve Eğitim Merkezi-KETEM) for the application of community-based cancer screening programs. In addition to these, obvious shortcomings related to education, implementation, management and research issues were also determined, and policy and project proposals to address these issues were presented. Collaboration with relevant organizations in the implementation of these studies was supported. CONCLUSION: Both the incidence and mortality rates of cancer are increasing in Turkey. The widespread deficiencies in population-based screening and in effective treatment lead to an increase in delay in diagnosis and mortality. Despite improvements in data recording, screening and treatment over the last 10 years, extensive, organized, population-based screening programs and fully equipped early diagnosis and treatment centers are required. Enhancement of basic cancer epidemiologic, translational, genetic and molecular research studies is essential in our country. Improvements on pain treatment and palliative care of patients with chronic and terminal cancer are also required.
Entities:
Keywords:
National Cancer Institute; Turkey; Workshop; cancer; incidence; prevention; screening
Authors: Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2015-02-04 Impact factor: 508.702
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Thomas J Smith; Sarah Temin; Erin R Alesi; Amy P Abernethy; Tracy A Balboni; Ethan M Basch; Betty R Ferrell; Matt Loscalzo; Diane E Meier; Judith A Paice; Jeffrey M Peppercorn; Mark Somerfield; Ellen Stovall; Jamie H Von Roenn Journal: J Clin Oncol Date: 2012-02-06 Impact factor: 44.544